Eli Lilly subsidiary, Precision Biosciences end gene therapy collaboration
https://seekingalpha.com/news/4090270-eli-lilly-subsidiary-precision-biosciences-end-gene-therapy-collaboration?source=feed_sector_healthcare
Apr 16, 2024 - Precision BioSciences (DTIL) said Eli Lilly (LLY) subsidiary Prevail Therapeutics has decided to conclude their gene therapy collaboration. Read more here.
0
Eli Lilly launches construction of $2.5B plant to meet obesity drug demand
https://seekingalpha.com/news/4088326-eli-lilly-eyes-25b-plant-make-obesity-drugs?source=feed_sector_healthcare
Apr 09, 2024 - Eli Lilly (LLY) begins construction of a $2.5B manufacturing plant in Germany to meet demand for its weight loss therapy tirzepatide. Read more here.
0
Eli Lilly's Wegovy Competitor Is Causing Supply Constraints: What It Means for the Stock
https://www.fool.com/investing/2024/04/06/eli-lillys-wegovy-competitor-is-causing-supply-con/?source=iedfolrf0000001
Apr 06, 2024 - Things are going exactly as planned for the biotech giant.
0
Top Stock Reports for Apple, NVIDIA & Eli Lilly
https://www.zacks.com/commentary/2248263/top-stock-reports-for-apple-nvidia-eli-lilly?cid=CS-ZC-FT-research_daily-2248263
Apr 01, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Apple Inc. (AAPL), NVIDIA Corporation (NVDA) and Eli Lilly and Company (LLY).
0
Eli Lilly tops S&P 500 healthcare sector in Q1 as weight loss frenzy continues
https://seekingalpha.com/news/4084974-eli-lilly-tops-the-growth-chart-for-the-sp-500-index-in-q1-as-the-sector-gains-momentum?source=feed_sector_healthcare
Mar 30, 2024 - The Health Care Select Sector SPDR Fund ETF (XLV) lagged slightly behind the S&P 500 index in Q1 2024, rising 8.31% compared to the overall market's 10.04%...
0
Eli Lilly vs. Berkshire Hathaway: Which Stock Will Become the Next Member of the $1 Trillion Club?
https://www.fool.com/investing/2024/03/28/eli-lilly-vs-berkshire-hathaway-which-stock-will-b/?source=iedfolrf0000001
Mar 28, 2024 - Don't assume that because Berkshire is worth nearly $900 billion, it's sure to get to $1 trillion first.
0
Elie Hassenfeld Q&A: ‘$5,000 to Save a Life Is a Bargain’
https://www.wired.com/story/elie-hassenfeld-givewell-ea/
Mar 27, 2024 - As Sam Bankman-Fried’s downfall sends effective altruism into a spiral of self-doubt, the idealist quant Elie Hassenfeld is still helping Silicon Valley richies give away hundreds of millions each year.
0
Eli Lilly (LLY) Advances While Market Declines: Some Information for Investors
https://www.zacks.com/stock/news/2246297/eli-lilly-lly-advances-while-market-declines-some-information-for-investors?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2246297
Mar 26, 2024 - In the most recent trading session, Eli Lilly (LLY) closed at $774.90, indicating a +0.23% shift from the previous trading day.
0
2seventy bio appoints Eli Casdin and Charles Newton to its board of directors
https://seekingalpha.com/news/4081841-2seventy-bio-appoints-eli-casdin-and-charles-newton-to-its-board-of-directors?source=feed_sector_healthcare
Mar 20, 2024 - 2seventy bio (TSVT) announces the appointment of Eli Casdin and Charles Newton to its board of directors.
0
Eli Lilly Zepbound prescriptions exceed Novo’s Wegovy for the first time in U.S.
https://seekingalpha.com/news/4080150-eli-lilly-zepbound-prescriptions-exceed-novos-wegovy?source=feed_sector_healthcare
Mar 15, 2024 - Eli Lilly's (LLY) weight loss drug Zepbound surpasses Novo Nordisk's (NVO) rival therapy Wegovy in terms of new US prescriptions for the first time. Read more here.
0